No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
357 |
4. Check minimum number of eventsNone |
357 |
5. Include endpointsNone |
357 |
6. Filter based on genotype QC (FinnGen only) |
357 |
Control definitions (FinnGen only)
- Control exclude
- M13_ARTHROPATHIES
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M21
- Name in latin
- Inaequalitas hongitudinis membrorum (acquisita)
Similar endpoints
↥List of similar endpoints to
Unequal limb length (acquired)
based on the number of shared cases.
Similar with more cases:
- Other joint disorders
- Arthropathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5169 | 2272 | 2894 |
| Only index persons | 4933 | 2151 | 2782 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.07 | 0.07 | 0.08 |
| Only index persons | 0.09 | 0.08 | 0.11 |
| Median age at first event (years) | |||
| Whole population | 13.10 | 12.57 | 13.51 |
| Only index persons | 13.24 | 12.74 | 13.63 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 357 | 218 | 139 |
| Unadjusted period prevalence (%) | 0.07 | 0.07 | 0.06 |
| Median age at first event (years) | 14.20 | 14.08 | 14.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 316
- Matched controls
- 3159
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M21.7
ICD-10 Finland
Unequal limb length (acquired)
+∞
323.0
316
*
NFK20
NOMESCO Finland
Epiphysiodesis of femur
413.4
37.9
37
*
NGK20
NOMESCO Finland
Epiphysiodesis of knee or lower leg
345.2
31.4
31
*
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
141.1
25.0
26
*
M16.1
ICD-10 Finland
Other primary coxarthrosis
82.5
21.0
23
*
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
24.5
19.4
27
12
M17.1
ICD-10 Finland
Other primary gonarthrosis
24.5
18.0
25
11
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
15.8
18.0
29
20
NFU20
NOMESCO Finland
Removal of internal fixation device from femur
39.2
17.8
22
6
M25.5
ICD-10 Finland
Pain in joint
3.8
16.2
76
243
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
28.0
15.8
21
8
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
7.5
15.2
36
53
NF1AA
NOMESCO Finland
Hip X-ray examination
15.2
14.8
24
17
NFB30
NOMESCO Finland
Primary total prosthetic replacement of hip joint not using cement
78.6
13.7
15
*
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
146.0
13.6
14
*
NK6JD
NOMESCO Finland
Ortopaedic measurement of extemities with CT
+∞
12.6
12
*
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
135.1
12.5
13
*
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
135.1
12.5
13
*
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
7.6
12.1
28
40
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
7.1
12.1
29
44
N03AX12
ATC
gabapentin; oral
4.2
10.5
40
105
M70.6
ICD-10 Finland
Trochanteric bursitis
5.7
10.3
29
55
N02AX02
ATC
tramadol; systemic, rectal
2.6
10.2
86
397
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
8.0
9.6
21
28
M19.0
ICD-10 Finland
Primary arthrosis of other joints
31.1
9.5
12
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
31.1
9.5
12
*
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
103.0
9.5
10
*
M08.4
ICD-10 Finland
Pauciarticular juvenile arthritis
+∞
9.4
9
*
ZXA00
NOMESCO Finland
Right side
2.8
9.4
63
254
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
7.1
9.3
22
33
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.3
9.0
105
570
M21.4
ICD-10 Finland
Flat foot [pes planus] (acquired)
19.3
9.0
13
7
L13
ICPC
Hip symptom/complaint
4.2
9.0
34
89
WX320
NOMESCO Finland
Spinalanesthesy
3.1
8.6
49
178
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.7
8.5
37
110
NJ3NA
NOMESCO Finland
Measurement of difference in extremity lengty with X-ray
92.4
8.5
9
*
Q72.88
ICD-10 Finland
Other reduction defects of lower himb(s)
92.4
8.5
9
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
10.4
8.1
15
15
N03AX16
ATC
pregabalin; oral
3.0
8.1
49
184
M75.1
ICD-10 Finland
Rotator cuff syndrome
3.2
8.0
44
153
S82.2
ICD-10 Finland
Fracture of shaft of tibia
8.1
8.0
17
22
M13.9
ICD-10 Finland
Arthritis, unspecified
9.8
7.9
15
16
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
5.0
7.8
24
51
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.8
7.8
25
56
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.3
7.7
76
379
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
18.9
7.7
11
6
B01AB05
ATC
enoxaparin; parenteral
2.6
7.6
59
259
NFK50
NOMESCO Finland
Shortening osteotomy of femur
+∞
7.3
7
*
M21.0
ICD-10 Finland
Valgus deformity, not elsewhere classified
+∞
7.3
7
*
NJ3MA
NOMESCO Finland
Measurement of extremity length with X-ray
+∞
7.3
7
*
NFC20
NOMESCO Finland
Secondary implantation of hip prosthesis
+∞
7.3
7
*
NGU20
NOMESCO Finland
Removal of internal fixation device from knee or lower leg
12.4
7.1
12
10
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
6.6
7.0
17
27
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
9.6
6.8
13
14
M41.9
ICD-10 Finland
Scoliosis, unspecified
9.6
6.8
13
14
S72.3
ICD-10 Finland
Fracture of shaft of femur
17.1
6.8
10
6
NFK30
NOMESCO Finland
Angulation, rotation or displacement osteotomy of femur
40.9
6.8
8
*
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
4.1
6.8
25
65
M54.4
ICD-10 Finland
Lumbago with sciatica
2.9
6.7
40
151
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.7
6.5
27
78
M79.6
ICD-10 Finland
Pain in limb
2.1
6.5
88
499
M20.4
ICD-10 Finland
Other hammer toe(s) (acquired)
71.2
6.4
7
*
9165
FHL
Removal of osteosynthesis material
14.7
6.4
10
7
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.8
6.4
15
23
L04AA13
ATC
leflunomide; oral
+∞
6.3
6
*
M22.0
ICD-10 Finland
Recurrent dislocation of patella
+∞
6.3
6
*
NF1DA
NOMESCO Finland
X-ray of hips
27.3
6.3
8
*
ZXA05
NOMESCO Finland
Left side
2.5
6.2
49
216
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
4.9
6.2
19
41
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.2
224
1787
P01BA02
ATC
hydroxychloroquine; oral
7.9
6.2
13
17
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.1
6.1
18
37
M43.1
ICD-10 Finland
Spondylolisthesis
8.9
6.1
12
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
6.1
86
496
M01AH05
ATC
etoricoxib; oral
1.9
6.1
117
754
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
6.2
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
126
771
1.98
8.21
6.2
5.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
98
548
2.09
8.19
2.0
1.9
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
116
720
1.91
7.07
2.2
2.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
162
1142
1.77
6.38
6.7
5.4
%
0.6
0.6
0.17
152
1065
(3006504) Eosinophils/100 leukocytes in Blood
166
1184
1.75
6.24
6.6
5.2
%
2.9
2.7
0.43
156
1104
(3013115) Eosinophils [#/volume] in Blood
177
1294
1.73
6.03
6.4
5.5
e9/l
0.2
0.2
0.26
161
1133
(3019069) Monocytes/100 leukocytes in Blood
166
1193
1.73
6.01
6.7
5.5
%
8.5
8.2
0.69
157
1121
(3037522) Nuclear Ab [Titer] in Serum
52
262
2.15
5.58
1.2
1.4
titre
708.6
477.1
—
7
42
(3019198) Lymphocytes [#/volume] in Blood
178
1323
1.69
5.56
6.3
5.1
e9/l
1.9
2.1
1.21
165
1170
(3018010) Neutrophils/100 leukocytes in Blood
170
1252
1.68
5.47
6.4
5.0
%
55.6
55.4
0.09
160
1179
(3001604) Monocytes [#/volume] in Blood
169
1243
1.68
5.46
6.5
5.2
e9/l
0.6
0.5
0.78
152
1066
(3044941) Cell count panel - Synovial fluid
8
5
16.31
5.43
2.1
1.0
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
172
1274
1.68
5.39
6.6
5.1
%
30.4
30.8
0.21
163
1194
(3006315) Basophils [#/volume] in Blood
169
1248
1.67
5.35
6.5
5.2
e9/l
0.0
0.0
0.19
152
1069
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
215
1694
1.68
5.27
7.6
5.6
u/l
77.3
77.4
0.01
198
1574
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
53
288
1.99
4.65
1.5
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
104
697
1.69
4.62
2.6
2.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
129
917
1.64
4.56
2.9
2.2
nmol/l
74.0
71.6
0.48
119
834
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
155
1163
1.59
4.34
4.5
3.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
123
874
1.62
4.32
1.7
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
144
1066
1.59
4.25
5.0
5.3
umol/l
10.0
10.8
0.62
129
996
(3024522) Salmonella sp identified in Specimen by Organism specific culture
10
23
4.44
4.11
1.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
10
23
4.44
4.11
1.0
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
185
1461
1.55
4.06
8.0
7.8
e9/l
3.8
4.0
0.55
164
1257
(3024561) Albumin [Mass/volume] in Serum or Plasma
112
788
1.61
4.05
4.6
4.5
g/l
37.9
37.6
0.26
106
738
(3013512) EKG study
74
467
1.74
4.05
2.6
2.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
76
484
1.72
4.02
2.2
2.0
mg/l
0.6
0.9
1.86
59
319
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
10
24
4.26
3.91
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
10
24
4.26
3.91
1.0
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
10
24
4.26
3.91
1.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
10
24
4.26
3.91
1.0
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
43
231
1.98
3.90
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
32
154
2.18
3.86
4.0
4.7
%
0.4
0.5
—
5
37
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
92
624
1.64
3.83
2.7
2.5
ng/l
17.3
41.0
1.13
49
294
(40767503) Oxygen content in Capillary blood by calculation
11
29
3.88
3.83
2.8
2.0
%
18.1
17.5
—
6
10
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
50
287
1.86
3.73
1.3
1.1
u/ml
12.7
1.4
0.54
22
112
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
119
867
1.56
3.66
6.4
5.6
mmol/l
1.2
1.2
0.14
112
788
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
52
306
1.82
3.59
1.4
1.1
iu/ml
19.1
12.8
0.47
11
78
(3004588) Protein electrophoresis panel - Serum or Plasma
17
64
2.74
3.44
1.3
3.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
76
2.58
3.44
1.5
2.0
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
56
342
1.76
3.42
3.0
2.7
ng/l
977.1
741.2
0.19
43
270
(3013826) Glucose [Moles/volume] in Serum or Plasma
170
1352
1.49
3.41
4.5
4.2
mmol/l
6.1
6.2
0.40
156
1188
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
27
128
2.20
3.39
4.4
3.6
mmol/l
1.0
1.6
0.64
18
93
(3013707) Erythrocyte sedimentation rate by Westergren method
205
1702
1.48
3.26
4.6
2.8
mm/h
8.7
8.2
0.25
189
1558
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
10
28
3.65
3.22
7.1
8.6
u/ml
0.5
0.4
—
5
15
(40760892) CBC W Ordered Manual Differential panel - Blood
87
607
1.57
3.18
4.5
3.7
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
0
81
0.00
3.18
0.0
1.1
—
1.1
—
0
19
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
126
956
1.49
3.13
7.3
6.0
mmol/l
1.2
1.2
0.40
108
821
(3021440) Promyelocytes/100 leukocytes in Blood
31
163
1.99
3.01
4.8
5.1
%
0.0
0.2
—
8
46
(3000991) Gas panel - Venous blood
30
156
2.01
3.00
4.6
6.7
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
5
10.12
2.98
2.8
1.8
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
5
10.12
2.98
2.8
1.8
%
9.0
4.8
—
5
5
(3000494) Fungus identified in Specimen by Culture
40
230
1.83
2.98
1.2
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
30
158
1.98
2.90
4.7
5.1
%
0.0
0.1
—
7
42
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
25
123
2.11
2.89
1.6
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
9
6.76
2.88
1.5
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
209
1767
1.44
2.87
4.4
3.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
62
411
1.62
2.79
2.9
3.4
mg/l
28.7
97.0
2.34
39
283
(3030905) Polymorphonuclear cells [#/volume] in Blood
11
37
3.04
2.71
3.9
3.0
e9/l
3.0
3.5
0.39
11
37
(3017181) Myelocytes/100 leukocytes in Blood
31
170
1.90
2.68
4.8
5.0
%
0.6
1.1
—
8
49
(3032080) INR in Blood by Coagulation assay
93
682
1.49
2.68
5.1
5.4
inr
1.0
1.1
2.52
31
243
(3025941) Bacteria identified in Stool by Culture
29
156
1.93
2.66
1.4
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
21
100
2.17
2.64
4.9
3.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
195
0.35
2.63
1.3
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
11
38
2.95
2.60
5.2
2.2
mmol/l
1.5
2.7
—
6
23
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
11
38
2.95
2.60
4.2
3.6
%
49.0
51.9
0.25
11
38
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
9
25
3.67
2.59
1.3
1.2
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
102
768
1.46
2.56
3.9
2.8
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
7
7.22
2.55
2.8
2.6
—
—
—
0
0
(4211845)
5
7
7.22
2.55
2.8
2.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
6
11
5.53
2.55
2.7
2.0
e9/l
0.1
0.2
—
6
11
(3023368) Bacteria identified in Blood by Culture
64
437
1.57
2.55
4.1
3.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
636
1.49
2.53
3.3
3.0
mmol/l
7.9
8.8
0.84
73
558
(3002582) Erythrocytes [#/volume] in Urine
91
675
1.47
2.46
3.0
2.7
e6/l
12.2
66.8
3.08
68
502
(1616796) Gas panel - Central venous blood
10
34
3.00
2.43
6.0
2.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
83
607
1.48
2.41
3.0
2.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
9
27
3.39
2.41
2.3
1.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
109
841
1.43
2.39
3.3
3.1
e6/l
10.9
78.7
4.46
73
535
(3030467) Casts [#/volume] in Urine by Automated count
82
602
1.47
2.33
3.1
2.6
e6/l
0.1
0.3
1.96
60
432
(3026782) Osmolality of Urine
64
447
1.53
2.31
2.6
2.3
mosm/kgh2o
564.1
561.8
0.02
56
379
(3015377) Calcium [Moles/volume] in Serum or Plasma
87
649
1.45
2.27
2.4
3.0
mmol/l
2.4
2.4
0.51
81
585
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
18
3.94
2.26
1.4
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
16
73
2.25
2.24
1.3
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
42
2.67
2.20
1.5
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
229
2019
1.37
2.17
4.3
3.9
mmol/mol
37.1
37.4
0.19
215
1887
(3002032) Base excess in Venous blood by calculation
31
184
1.75
2.12
2.1
5.3
mmol/l
1.4
1.9
0.57
24
140
(3028271) Lactate [Moles/volume] in Capillary blood
8
25
3.25
2.10
1.8
1.6
mmol/l
1.5
1.8
—
8
25
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
18
89
2.08
2.09
5.4
4.1
mmol/l
24.5
24.5
0.04
18
89
(3042936) Bacteria identified in Isolate by Culture
38
240
1.65
2.09
2.4
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
76
562
1.45
2.07
5.3
3.2
ph
7.4
7.4
0.16
21
105
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
78
580
1.44
2.07
2.2
1.9
mg/l
2.5
2.6
0.10
67
483
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
86
652
1.42
2.05
3.0
2.2
u/l
50.2
58.0
1.55
79
594
(3014051) Protein [Presence] in Urine by Test strip
12
50
2.45
2.04
3.6
2.0
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
6
15
4.05
2.04
1.3
1.9
umol/l
12.2
10.7
—
6
15
(3008898) HLA-B27 [Presence]
17
84
2.08
1.99
1.1
1.0
—
—
—
0
0
(3012544) pH of Venous blood
31
189
1.70
1.95
2.1
5.5
—
—
—
0
0
(3010421) pH of Blood
11
45
2.49
1.95
5.8
2.1
ph
7.4
7.4
0.05
11
37
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
27
3.01
1.94
2.9
3.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
60
430
1.48
1.92
3.9
4.1
mg/mmol
3.6
13.5
2.68
36
301
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
238
2131
1.35
1.92
4.5
3.6
pmol/l
14.6
14.5
0.14
219
1930
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
258
2339
1.37
1.92
10.8
7.7
ml/min/173m2
99.6
98.2
0.42
216
1775
(3003458) Phosphate [Moles/volume] in Serum or Plasma
38
246
1.61
1.91
8.2
6.0
mmol/l
1.1
1.1
0.07
38
232
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
272
2488
1.39
1.91
5.2
4.2
mu/l
1.8
1.8
0.06
260
2307
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
337
1.53
1.91
2.3
2.4
e6/l
0.8
0.9
0.12
25
174
(3022806) Fractional oxyhemoglobin in Capillary blood
7
22
3.22
1.89
1.9
1.6
%
93.0
92.0
—
7
22
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
53
0.00
1.88
0.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
31
191
1.68
1.88
1.5
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
160
1356
1.33
1.87
2.9
2.5
ug/l
98.5
74.6
0.79
144
1255
(3019225) pH of Specimen
28
168
1.72
1.87
4.6
3.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
34
216
1.63
1.84
1.7
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
521
1.43
1.84
4.2
3.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
62
451
1.45
1.84
2.8
2.2
e6/l
6.0
8.2
0.69
53
386
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
16
80
2.05
1.83
1.3
1.6
nmol/l
0.3
0.4
—
9
72
(3014111) Lactate [Moles/volume] in Serum or Plasma
26
154
1.74
1.82
4.5
5.9
mmol/l
1.0
1.3
1.92
26
142
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
295
2745
1.43
1.79
12.8
8.7
mg/l
21.2
21.6
0.06
234
1968
(40761536) Microorganisms panel - Urine sediment
37
242
1.59
1.79
4.3
3.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
25
147
1.75
1.79
10.7
7.6
mmol/l
5.7
6.6
0.78
25
142
(3045414) Leukocytes [Presence] in Urine
18
95
1.94
1.79
2.9
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
14
67
2.13
1.78
1.1
1.5
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
18
3.37
1.75
2.5
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
147
1242
1.31
1.72
3.9
2.9
estimate
0.0
0.0
0.00
38
253
(3009261) Glucose [Presence] in Urine by Test strip
148
1258
1.30
1.64
4.0
2.9
estimate
0.0
0.0
0.50
38
253
(3052851) Hemolysis interference index of Serum or Plasma
12
56
2.18
1.63
1.8
2.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
276
2554
1.36
1.62
13.0
9.2
mmol/l
3.9
3.9
0.02
269
2451
(3021601) Nitrite [Presence] in Urine by Test strip
146
1244
1.29
1.58
5.1
4.0
estimate
0.0
0.0
0.00
37
259
(3019550) Sodium [Moles/volume] in Serum or Plasma
275
2547
1.35
1.57
13.1
9.2
mmol/l
139.3
139.6
1.08
269
2453
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
57
2.14
1.57
2.2
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
55
405
1.42
1.54
3.5
2.5
umol/l
333.2
6099.3
1.77
48
367
(3049717) Cytology report of Urine Cyto stain
10
44
2.31
1.54
2.0
2.7
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
311
2941
1.45
1.54
11.5
8.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
27
2.62
1.52
1.4
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
27
2.62
1.52
1.0
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
305
2877
1.41
1.51
9.9
6.8
u/l
28.1
26.1
0.72
299
2765
(3044889) 12 lead EKG panel
165
1435
1.28
1.50
3.0
2.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
49
356
1.44
1.48
1.6
1.5
pmol/l
452.3
22112642.0
0.50
35
303
(3016502) Oxygen saturation in Arterial blood
21
125
1.72
1.47
6.2
10.5
%
96.7
96.4
0.17
21
119
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
28
2.53
1.46
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
39
272
1.49
1.45
1.7
1.6
nmol/l
1064.4
1190.4
0.36
30
205
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
21
126
1.71
1.43
2.6
2.5
ml/min/173m2
57.3
82.0
—
7
48
(3007461) Platelets [#/volume] in Blood
337
3250
1.66
1.40
18.0
12.7
e9/l
262.6
257.8
0.73
332
3151
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
242
1.49
1.36
3.2
2.9
%
30.4
32.2
0.44
26
175
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
17
2.97
1.36
1.0
7.4
—
31.6
—
0
5
(3029937) Albumin [Presence] in Urine by Test strip
82
661
1.31
1.32
4.2
3.0
estimate
0.0
0.0
0.80
38
255
(3003327) Ova and parasites identified in Stool by Light microscopy
18
106
1.74
1.32
1.3
1.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
36
253
1.47
1.30
1.8
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
138
1191
1.26
1.30
10.2
7.2
e9/l
0.0
0.0
0.29
121
941
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
18
2.80
1.29
1.4
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
57
437
1.36
1.28
3.7
2.6
ug/g
122.4
112.0
0.11
43
334
(3026361) Erythrocytes [#/volume] in Blood
337
3258
1.61
1.27
17.9
12.7
e12/l
4.6
4.6
0.94
332
3158
(3022217) INR in Platelet poor plasma by Coagulation assay
24
155
1.59
1.26
13.1
12.5
inr
1.0
1.1
—
8
34
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.25
1.5
1.2
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
29
197
1.51
1.24
3.9
4.3
u/l
236.7
238.0
0.02
29
190
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
5
19
2.65
1.22
2.8
2.4
—
11.7
—
0
14
(3002523) Influenza virus A Ag [Presence] in Specimen
12
64
1.91
1.19
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
64
1.91
1.19
1.2
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
39
2.07
1.16
1.4
1.7
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
28
193
1.49
1.13
1.5
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
112
958
1.25
1.12
3.9
2.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
47
606
0.74
1.11
1.4
1.5
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
21
2.40
1.09
1.4
3.0
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
21
2.40
1.09
2.4
2.1
pg
34.0
31.2
—
5
21
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
45
342
1.36
1.08
2.2
2.5
e6/l
4.4
3.4
0.24
22
181
(3002256) Pathology report gross observation
34
247
1.42
1.06
1.3
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
109
0.45
1.02
1.2
1.3
—
—
—
0
0
(4034850)
12
68
1.79
1.01
10.0
8.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
248
2318
1.23
1.01
3.6
3.0
mmol/l
5.6
5.6
0.14
231
2138
(3027801) Oxygen [Partial pressure] in Arterial blood
23
158
1.49
0.96
6.2
8.7
kpa
14.2
14.0
0.05
23
149
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
23
158
1.49
0.96
6.2
8.7
kpa
4.8
5.1
0.83
23
148
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
70
1.74
0.93
6.5
15.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
351
1.32
0.93
3.2
3.0
ng/l
47.2
597.8
1.30
33
200
(3000330) Specific gravity of Urine by Test strip
14
86
1.65
0.92
4.1
2.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
28
2.16
0.92
1.0
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
253
0.66
0.91
1.1
1.3
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
53
425
1.29
0.90
1.6
1.3
nmol/l
21.6
20.0
0.40
46
365
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
277
2634
1.23
0.88
3.6
3.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
80
1.65
0.85
3.4
3.9
g/l
0.1
0.3
—
7
41
(21494755) Public health laboratory ask at order entry panel
31
407
0.74
0.85
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
45
1.80
0.85
1.3
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
18
121
1.51
0.84
2.2
6.2
mmol/l
24.2
24.3
0.07
18
114
(3022621) pH of Urine by Test strip
19
130
1.49
0.82
3.6
2.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
14
89
1.60
0.82
1.6
1.3
—
—
—
0
0
(3020891) Body temperature
11
66
1.69
0.79
4.3
3.9
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(4027681)
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
33
1.83
0.79
1.2
2.3
g/l
9.8
9.4
—
6
33
(3003396) Base excess in Arterial blood by calculation
22
157
1.43
0.78
6.5
8.8
mmol/l
0.4
1.1
0.78
17
120
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
23
166
1.41
0.78
2.7
2.8
g/l
0.2
0.2
0.10
23
153
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
42
521
0.78
0.77
1.6
2.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
71
602
1.22
0.77
7.5
5.9
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
28
0.00
0.76
0.0
1.3
—
44.5
—
0
19
(40768443) Skin Pathology biopsy report
12
75
1.62
0.76
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
19
134
1.44
0.73
1.6
1.4
mg/l
2.3
3.1
—
10
79
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
255
2423
1.18
0.73
3.6
3.1
mmol/l
4.6
4.6
0.15
244
2286
(3003694) ABO and Rh group [Type] in Blood
114
1021
1.17
0.69
1.7
1.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
42
1.68
0.68
1.6
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
43
1.64
0.67
1.6
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
28
1.80
0.66
1.0
2.5
g/l
0.0
0.0
—
5
28
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
28
1.80
0.66
1.0
2.5
g/l
0.0
0.0
—
5
28
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
87
1.51
0.64
1.7
1.3
u/ml
240.0
201.0
—
5
51
(3035637) Corticotropin [Mass/volume] in Plasma
5
29
1.73
0.64
1.2
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
42
344
1.25
0.63
2.3
2.0
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
252
2404
1.16
0.63
3.5
3.0
mmol/l
1.4
1.5
1.83
242
2262
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
79
1.54
0.63
1.8
1.8
iu/l
2.3
6.5
—
5
25
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
38
308
1.26
0.63
1.8
2.7
mmol/l
2.4
2.4
0.21
33
277
(3027944) Amphetamines [Presence] in Urine
30
377
0.78
0.63
3.1
1.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
30
1.68
0.61
1.0
2.4
g/l
39.3
40.6
—
5
30
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
30
1.68
0.61
1.4
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
151
0.65
0.61
1.3
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
52
1.55
0.60
1.0
1.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
0.9
—
0
11
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
8
53
1.52
0.59
1.4
1.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
31
384
0.79
0.58
3.1
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
23
0.00
0.58
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
639
0.84
0.57
2.1
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
255
2443
1.15
0.57
3.9
3.3
mmol/l
2.8
2.8
0.33
242
2281
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
36
1.68
0.57
1.2
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
382
0.79
0.56
3.0
1.9
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
92
823
1.16
0.56
3.1
2.9
u/l
25.4
29.0
1.51
85
771
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
37
1.63
0.56
1.2
2.2
g/l
7.6
7.0
—
6
31
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
37
1.63
0.56
1.2
2.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
6
37
1.63
0.56
1.2
2.2
g/l
4.9
3.4
—
6
30
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
12
82
1.48
0.55
11.0
7.3
mg/l
1.1
1.1
0.12
12
76
(3007164) IgA [Mass/volume] in Serum or Plasma
81
721
1.16
0.53
1.5
1.4
g/l
2.3
2.0
0.75
52
431
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
83
1.46
0.52
1.3
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
63
551
1.17
0.51
1.9
1.6
mmol/l
1.4
1.3
0.35
53
473
(3000764) Benzodiazepines [Presence] in Urine
31
377
0.81
0.51
3.0
2.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
24
189
1.29
0.51
2.8
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
52
448
1.19
0.50
2.0
1.7
%
1.6
1.4
0.61
47
407
(3009542) Hematocrit [Volume Fraction] of Blood
288
2793
1.16
0.50
11.1
9.6
%
40.1
40.8
0.82
228
2307
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
239
2290
1.13
0.50
3.2
2.8
mmol/l
1.3
1.2
1.39
231
2157
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
8
118
0.67
0.46
2.1
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
11
77
1.44
0.46
1.9
1.8
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
112
1.35
0.45
1.5
1.8
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
230
0.77
0.45
1.4
1.7
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
202
1.26
0.45
1.5
1.3
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
92
0.65
0.43
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
12
87
1.39
0.42
1.6
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
32
1.57
0.42
1.8
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
32
1.57
0.42
1.0
2.4
g/l
0.0
0.0
—
5
32
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
96
1.37
0.42
3.3
3.9
%
94.2
90.5
0.24
13
91
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4281824)
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
5
34
1.48
0.40
1.2
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
28
233
1.22
0.40
1.1
1.3
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
10
137
0.72
0.40
1.1
1.2
—
15.9
—
0
7
(40761535) Cells panel - Urine sediment
18
142
1.28
0.39
5.9
2.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
27
226
1.21
0.37
3.7
3.9
%
24.1
21.6
—
10
96
(3016879) Cocaine [Presence] in Urine
30
351
0.84
0.36
3.0
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
13
99
1.32
0.36
1.6
1.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
90
830
1.11
0.35
1.4
1.4
u/ml
2.1
1.2
0.29
31
201
(3009466) Valproate [Moles/volume] in Serum or Plasma
6
45
1.34
0.34
3.0
5.4
umol/l
368.0
411.9
—
6
40
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
89
0.67
0.33
1.0
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
12
92
1.31
0.32
3.9
9.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
7
54
1.30
0.30
1.7
15.0
mmol/l
1.1
1.1
—
7
47
(1002224) Polysomnography panel
13
102
1.28
0.30
1.2
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
81
751
1.10
0.29
3.3
2.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
107
0.74
0.29
1.4
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
63
577
1.11
0.29
4.0
2.9
kg/l
1.0
1.0
—
10
77
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
13
103
1.27
0.28
2.3
2.3
ug/l
5.0
7.1
0.30
13
88
(3011288) Drugs identified in Urine by Screen method
30
262
1.16
0.27
2.4
2.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
286
0.86
0.25
3.4
2.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
44
484
0.90
0.24
1.5
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
201
0.84
0.24
1.5
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
201
0.84
0.24
1.5
1.5
—
—
—
0
0
(4306422)
5
38
1.32
0.23
1.6
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
39
1.29
0.23
2.2
1.6
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29
258
1.13
0.22
5.2
3.0
umol/l
5.1
8.2
1.03
23
214
(40768806) Pleura Pathology biopsy report
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.0
—
10.2
—
0
10
(3044927) Protein electrophoresis panel - Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
198
0.85
0.21
1.5
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.6
—
104.9
—
0
14
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
2.5
—
0
14
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
0
14
0.00
0.20
0.0
1.1
—
1.1
—
0
7
(3041354) Potassium [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.6
—
4.0
—
0
14
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.7
—
22.6
—
0
14
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
9
113
0.79
0.20
1.9
2.5
u/ml
28.9
44.1
—
9
106
(3017143) Hepatitis C virus Ab [Presence] in Serum
52
559
0.92
0.19
1.4
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
53
1.13
0.19
1.2
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
16
185
0.86
0.18
1.3
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
77
730
1.07
0.18
2.1
1.5
pmol/l
99.8
96.1
0.35
37
362
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
22
195
1.14
0.18
7.9
4.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
120
0.83
0.17
1.2
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
80
0.75
0.15
1.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
80
0.75
0.15
1.2
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
62
587
1.07
0.15
1.5
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
106
1022
1.05
0.14
2.5
2.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
27
295
0.91
0.14
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
117
1209
0.95
0.14
1.9
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
14
160
0.87
0.14
3.0
2.4
ug/l
0.8
0.7
—
8
86
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
194
1900
1.05
0.14
2.9
2.6
u/l
34.7
31.4
0.38
183
1815
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
35
325
1.09
0.13
1.3
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
104
1.16
0.12
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
23
251
0.91
0.12
1.6
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
15
168
0.89
0.12
1.3
1.3
—
—
—
0
0
(4035726)
16
143
1.12
0.11
1.4
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
96
929
1.05
0.11
2.4
2.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
209
0.90
0.11
1.6
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
23
250
0.91
0.11
1.6
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
23
249
0.92
0.10
1.6
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
26
279
0.93
0.10
1.5
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
44
1.14
0.10
1.6
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
45
1.11
0.10
1.2
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
23
248
0.92
0.10
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
46
1.09
0.09
1.0
1.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
48
1.04
0.09
1.4
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
54
1.11
0.09
1.2
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
6
55
1.09
0.09
2.0
13.9
%
0.7
1.0
—
6
49
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
6
56
1.07
0.08
2.0
13.6
%
1.4
1.7
—
6
48
(3041806) Other cells [#/volume] in Blood by Manual count
6
56
1.07
0.08
1.3
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
30
318
0.94
0.08
1.5
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
58
1.04
0.08
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
5
61
0.82
0.08
3.0
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
102
996
1.03
0.08
1.6
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
92
943
0.97
0.08
1.6
1.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
75
0.80
0.07
1.0
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
8
75
1.07
0.07
1.0
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
77
1.04
0.07
1.3
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
96
938
1.03
0.07
2.2
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
91
0.88
0.07
2.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
23
244
0.94
0.06
1.1
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
17
158
1.08
0.06
4.4
2.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
11
100
1.10
0.05
2.2
2.2
e6/l
0.0
0.1
1.86
11
95
(3013139) Helicobacter pylori Ag [Presence] in Stool
16
150
1.07
0.04
1.3
1.2
—
—
—
0
0
(3000492) Spirometry study
26
249
1.05
0.04
1.2
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
35
361
0.97
0.03
1.2
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
30
307
0.98
0.01
2.9
2.5
u/l
9408.4
3501.8
0.31
11
140
(3001019) Free T4 and TSH panel - Serum or Plasma
17
164
1.04
0.00
1.3
1.5
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
254
1.03
0.00
1.3
1.2
iu/ml
84.1
139.7
0.91
13
95
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
128
1.02
0.00
1.3
1.4
—
—
—
0
0
(4010399)
14
139
1.01
0.00
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
234
0.98
0.00
2.0
1.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
6
0.00
0.00
0.0
1.8
—
109.9
—
0
6
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.4
—
0
6
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(4133840)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
113.2
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
85
0.94
0.00
2.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
13.2
—
0.5
—
0
6
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
84
840
1.00
0.00
1.5
1.9
—
—
—
0
0
(3035880) pH of Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.4
—
58.7
—
0
5
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
59
1.02
0.00
2.5
2.7
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
0
6
0.00
0.00
0.0
3.3
—
148.2
—
0
6
(3010937) Rubella virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
7
0.00
0.00
0.0
2.0
—
106.5
—
0
7
(3044290) Cell count panel - Cerebral spinal fluid
5
53
0.94
0.00
1.4
2.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
7.0
—
0
7
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
89
1.01
0.00
1.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
9
0.00
-0.00
0.0
5.6
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
9
0.00
-0.00
0.0
2.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
0
9
0.00
-0.00
0.0
5.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_LIMBLENGTH and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have M13_LIMBLENGTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: M13_LIMBLENGTH – Unequal limb length (acquired)
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data